RxDoctor Payments Data

Jill McDaniel

Gerontology · Greensboro, NCNPI 1023591807

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,098 of the $2,694 with a category attached, or 77.9%. 14 manufacturers reported payments, led by Edwards Lifesciences at 49.9% of the total. Reporting peaked in 2022 at $1,344 and has fallen 99.0% since, to $14 in 2025.

$2,694in general payments, 2019–2025

Across 87 payments — averaging $30.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$1K
  • Amgen$456
  • Medtronic$188
  • Sanofi-aventis U.S. LLC$154
  • Heartflow, Inc.$103
  • Irhythm Technologies, Inc.$101
  • plus $348 from 8 others

What the payments were for

  • Travel & lodging$59522%
  • Food & beverage$2,09878%
  • Education$10%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,694 in reported general payments places this provider in the 85th percentile of 165 gerontology providers in North Carolina.

See all gerontology providers in North Carolina

Medicare billing

Part B allowed, 2024
$10,827
Medicare patients
90
Services billed
159

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban64$51,980
EntrestoSacubitril/Valsartan18$18,871
XareltoRivaroxaban13$10,365
ClopidogrelClopidogrel Bisulfate121$1,735
Metoprolol Succinate68$716
Metoprolol Tartrate43$478
Diltiazem 24hr Er (Cd)Diltiazem Hcl12$350
Furosemide54$318
Hydralazine Hcl22$311
Atorvastatin Calcium15$300
Pantoprazole Sodium21$272
Losartan Potassium25$266
Potassium Chloride22$234
Amoxicillin105$175
Amiodarone Hcl17$175

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$82$10,36513 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 165 gerontology providers in North Carolina.

Other gerontology in Greensboro

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →